- Seed Round,
- Early stage VC,
- Later stage VC
Developer of reformulated biopharmaceutical drugs designed to identify biologics and small molecules to improve patient care. The company's drugs are produced reformulated product or a new chemical entity, to identify regulatory strategies to expedite the path to approval through efficient clinical programs, enabling pharma/biotech companies to meet their drug demands to improve patient's lives.
- CompanyAmountRound
- Example example company Inc1000000Investor meetings
- Company & Company11000000Series C funding
- Example524000Seed round A
Email visible after logging in
Example Exampleexample
